Armando E Gonzalez Selected Research

Armando E Gonzalez Research Topics

Disease

37	Cysticercosis 04/2024 - 10/2003
28	Cysts 04/2024 - 10/2003
25	Neurocysticercosis 04/2024 - 10/2002
21	Infections 04/2024 - 09/2004
13	Taeniasis 01/2023 - 10/2003
8	Echinococcosis (Hydatid Cysts) 12/2015 - 10/2003
7	Inflammation (Inflammations) 01/2020 - 10/2003
5	Seizures (Absence Seizure) 11/2021 - 10/2002
2	Parasitic Diseases (Parasitic Disease) 01/2019 - 06/2005
2	Body Weight (Weight, Body) 01/2019 - 01/2016
2	Cestode Infections (Tapeworm Infection) 10/2014 - 06/2004
1	Persistent Infection 01/2022
1	Central Nervous System Cysts (Suprasellar Cyst) 01/2022
1	Hepatic Echinococcosis 01/2019
1	Trematode Infections (Fasciolopsiasis) 01/2019
1	Alopecia (Baldness) 01/2019
1	Lymphoma (Lymphomas) 03/2015
1	Epilepsy (Aura) 02/2014
1	Central Nervous System Infections (Central Nervous System Infection) 08/2012
1	Encephalitis (Encephalitis, Rasmussen) 06/2006
1	Cicatrix (Scar) 10/2003
1	Intracranial Hypertension 10/2002

Drug/Important Bio-Agent (IBA)

24	AntigensIBA 04/2024 - 10/2003
20	EnzymesIBA 04/2024 - 09/2004
17	AntibodiesIBA 04/2023 - 10/2003
17	Antiparasitic Agents (Antiparasitics)IBA 01/2022 - 10/2002
11	oxfendazoleIBA 04/2021 - 09/2004
9	ImmunosorbentsIBA 04/2024 - 09/2004
9	Albendazole (Albenza)FDA Link 11/2021 - 01/2004
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2004
8	Praziquantel (Biltricide)FDA Link 11/2019 - 02/2010
7	Glycoproteins (Glycoprotein)IBA 01/2019 - 09/2004
7	lentil lectinIBA 01/2019 - 09/2004
6	AnthelminticsIBA 10/2020 - 03/2015
5	brain synaptic membrane glycoprotein gp 50 (GP50)IBA 01/2019 - 01/2010
5	VaccinesIBA 12/2012 - 10/2003
4	Niclosamide FDA Link 01/2021 - 03/2004
4	Evans Blue (Blue, Evans)FDA Link 11/2017 - 01/2014
4	ChemokinesIBA 03/2015 - 09/2005
4	Recombinant ProteinsIBA 05/2014 - 06/2004
3	Monoclonal AntibodiesIBA 04/2024 - 03/2009
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021 - 01/2004
2	benzimidazoleIBA 10/2020 - 01/2019
2	GadoliniumIBA 06/2017 - 01/2016
2	CytokinesIBA 03/2015 - 02/2012
2	Peptides (Polypeptides)IBA 05/2014 - 06/2012
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2014 - 01/2004
2	Coloring Agents (Dyes)IBA 01/2014 - 02/2010
2	nitazoxanide (NTZ)FDA Link 08/2012 - 03/2009
2	Synthetic Vaccines (Recombinant Vaccines)IBA 04/2011 - 04/2006
1	Immunoglobulin G (IgG)IBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	albendazole sulfoxideIBA 11/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2017
1	Metalloproteases (Metalloproteinases)IBA 11/2017
1	InterferonsIBA 11/2017
1	InterleukinsIBA 11/2017
1	Peptide Hydrolases (Proteases)FDA Link 11/2017
1	Etanercept (Enbrel)FDA Link 11/2017
1	Matrix Metalloproteinases (MMPs)IBA 11/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017
1	AngiopoietinsIBA 11/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2017
1	TriclabendazoleIBA 01/2016
1	Capsules (Microcapsules)IBA 01/2016
1	Contrast MediaIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	Prednisone (Sone)FDA LinkGeneric 08/2012
1	Indicators and Reagents (Reagents)IBA 04/2012
1	Drug CombinationsIBA 02/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 02/2010
1	DNA (Deoxyribonucleic Acid)IBA 07/2008
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2008
1	NF-kappa B (NF-kB)IBA 06/2006
1	EpitopesIBA 05/2006
1	DisulfidesIBA 05/2006
1	Cathartics (Purgatives)IBA 03/2004
1	PlacebosIBA 01/2004

Therapy/Procedure

8	Therapeutics 11/2019 - 10/2002
5	Aftercare (After-Treatment) 11/2021 - 01/2004
1	Retreatment 11/2021
1	Mass Drug Administration 01/2021
1	Immunomodulation 02/2012